Primecap Management’s Exact Sciences EXAS Stock Holding History

Primecap Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,300	Closed	-$3.48M	–	323
2025 Q4	$3.48M	Sell	34,300 -344,100	-91%	-$27.6M	﹤0.01%	288
2025 Q3	$20.7M	Hold	378,400	–	–	0.02%	240
2025 Q2	$20.1M	Sell	378,400 -100,900	-21%	-$5.13M	0.02%	241
2025 Q1	$20.7M	Hold	479,300	–	–	0.02%	228
2024 Q4	$26.9M	Sell	479,300 -17,000	-3%	-$1.06M	0.02%	221
2024 Q3	$33.8M	Hold	496,300	–	–	0.02%	206
2024 Q2	$21M	Buy	496,300 +17,000	+4%	+$935K	0.02%	227
2024 Q1	$33.1M	Hold	479,300	–	–	0.02%	212
2023 Q4	$35.5M	Hold	479,300	–	–	0.03%	203
2023 Q3	$32.7M	Hold	479,300	–	–	0.03%	201
2023 Q2	$45M	Hold	479,300	–	–	0.04%	184
2023 Q1	$32.5M	Hold	479,300	–	–	0.03%	196
2022 Q4	$23.7M	Hold	479,300	–	–	0.02%	209
2022 Q3	$15.6M	Hold	479,300	–	–	0.02%	222
2022 Q2	$18.9M	Sell	479,300 -25,000	-5%	-$1.34M	0.02%	221
2022 Q1	$35.3M	Sell	504,300 -28,000	-5%	-$2.05M	0.03%	205
2021 Q4	$41.4M	Sell	532,300 -38,500	-7%	-$3.4M	0.03%	202
2021 Q3	$54.5M	Sell	570,800 -5,000	-0.9%	-$528K	0.04%	194
2021 Q2	$71.6M	Sell	575,800 -9,000	-2%	-$1.07M	0.05%	178
2021 Q1	$77.1M	Sell	584,800 -70,600	-11%	-$9.66M	0.05%	168
2020 Q4	$86.8M	Sell	655,400 -510,200	-44%	-$61.7M	0.06%	156
2020 Q3	$119M	Sell	1,165,600 -140,500	-11%	-$12.1M	0.1%	130
2020 Q2	$114M	Sell	1,306,100 -87,100	-6%	-$6.96M	0.1%	130
2020 Q1	$80.8M	Sell	1,393,200 -113,300	-8%	-$9.2M	0.08%	135
2019 Q4	$139M	Buy	1,506,500 +6,000	+0.4%	+$527K	0.1%	126
2019 Q3	$136M	Sell	1,500,500 -282,600	-16%	-$32.2M	0.11%	127
2019 Q2	$210M	Sell	1,783,100 -1,206,100	-40%	-$122M	0.16%	119
2019 Q1	$259M	Sell	2,989,200 -205,902	-6%	-$17.5M	0.19%	108
2018 Q4	$202M	Sell	3,195,102 -383,998	-11%	-$26.4M	0.16%	111
2018 Q3	$282M	Hold	3,579,100	–	–	0.19%	106
2018 Q2	$214M	Hold	3,579,100	–	–	0.16%	113
2018 Q1	$144M	Hold	3,579,100	–	–	0.11%	129
2017 Q4	$188M	Sell	3,579,100 -557,600	-13%	-$29.8M	0.14%	116
2017 Q3	$195M	Sell	4,136,700 -364,600	-8%	-$14.7M	0.16%	114
2017 Q2	$159M	Buy	4,501,300 +10,000	+0.2%	+$309K	0.14%	119
2017 Q1	$106M	Hold	4,491,300	–	–	0.1%	132
2016 Q4	$60M	Hold	4,491,300	–	–	0.06%	151
2016 Q3	$83.4M	Sell	4,491,300 -25,000	-0.6%	-$441K	0.08%	133
2016 Q2	$55.3M	Hold	4,516,300	–	–	0.06%	158
2016 Q1	$30.4M	Buy	4,516,300 +1,420,000	+46%	+$9.08M	0.03%	185
2015 Q4	$28.6M	Buy	3,096,300 +360,000	+13%	+$3.35M	0.03%	191
2015 Q3	$49.2M	Buy	2,736,300 +105,000	+4%	+$2.41M	0.05%	169
2015 Q2	$78.3M	Buy	2,631,300 +105,000	+4%	+$2.64M	0.08%	153
2015 Q1	$55.6M	Buy	2,526,300 +5,000	+0.2%	+$127K	0.05%	167
2014 Q4	$69.2M	Buy	2,521,300 +25,000	+1%	+$608K	0.07%	152
2014 Q3	$48.4M	Buy	2,496,300 +5,000	+0.2%	+$91.7K	0.05%	168
2014 Q2	$42.4M	Buy	+2,491,300	New	+$34.3M	0.05%	167

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Primecap Management's EXAS Position: Q1 2026 in Review

Primecap Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 34,300 shares — an estimated $3.48M sold.

Primecap Management first reported a position in EXAS in Q2 2014 and held it in 47 quarters. The position peaked at $282M in Q3 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Primecap Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Primecap Management sold 34,300 Exact Sciences shares in Q1 2026, an estimated $3.48M.
Primecap Management first reported a position in Exact Sciences in Q2 2014 and held it in 47 quarters.
Primecap Management's Exact Sciences position peaked at $282M in Q3 2018.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Primecap Management's 13F filing for Q1 2026, filed 11 May 2026.